NCT00609557View on ClinicalTrials.gov

A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
OsteoarthritisPain
Interventions
DRUG

duloxetine

Weeks 0-2 placebo Weeks 2-3 30mg duloxetine Weeks 3-4 60mg duloxetine Weeks 4-12 60-90mg duloxetine Week 13 30 mg duloxetine Week 14 stop

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Washington

OTHER

NCT00609557 - A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoarthritis Pain | Biotech Hunter | Biotech Hunter